Scarica l'app Stockscreener
18.95
4.92%
-0.98
Dopo l'orario di chiusura:
18.95
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
Ameriprise Financial Inc. Raises Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Millennium Management LLC Trims Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Rating of “Buy” by Analysts - Defense World
Cantor Fitzgerald maintains Vera Therapeutics at Overweight By Investing.com - Investing.com Canada
Buy Rating for Vera Therapeutics Driven by Promising Phase III Results and Market Potential - TipRanks
BNP Paribas Financial Markets Purchases Shares of 24,374 Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics Holds 2025 Annual Stockholder Meeting - TipRanks
Dimensional Fund Advisors LP Trims Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics: Huge Catalyst Upcoming For Kidney Disease Drug (NASDAQ:VERA) - Seeking Alpha
How To Trade (VERA) - news.stocktradersdaily.com
Research Analysts Set Expectations for VERA FY2025 Earnings - Defense World
Northern Trust Corp Has $19.24 Million Stock Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
IgA Nephropathy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharmaceuticals - The Globe and Mail
FY2025 EPS Estimates for VERA Decreased by Cantor Fitzgerald - Defense World
Q2 EPS Forecast for Vera Therapeutics Reduced by Analyst - Defense World
Q2 EPS Estimates for Vera Therapeutics Boosted by Wedbush - Defense World
Hsbc Holdings PLC Takes $264,000 Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - The AM Reporter
Cantor Fitzgerald Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $100.00 - Defense World
Wedbush Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $26.00 - Defense World
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
What is Wedbush’s Estimate for VERA Q1 Earnings? - Defense World
Analysts Set Expectations for VERA Q2 Earnings - Defense World
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Vera Therapeutics (VERA) and Dexcom (DXCM) - The Globe and Mail
Analysts Issue Forecasts for VERA Q1 Earnings - Defense World
Decoding Vera Therapeutics Inc (VERA): A Strategic SWOT Insight - GuruFocus
Ratios Reveal: Breaking Down Vera Therapeutics Inc (VERA)’s Financial Health - DWinneX
Vera Therapeutics (VERA) Price Target Adjusted by Cantor Fitzgerald | VERA Stock News - GuruFocus
Vera Therapeutics Advances Atacicept in Key Trials - TipRanks
Vera Therapeutics shares fall as Q1 loss exceeds estimates By Investing.com - Investing.com India
Vera Therapeutics shares fall as Q1 loss exceeds estimates - Investing.com Australia
Medtronic gains after boosting full-year guidance By Investing.com - Investing.com India
Vera Therapeutics reports Q1 EPS (81c), consensus (78c) - TipRanks
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Vera Therapeutics (VERA) - The Globe and Mail
Vera Therapeutics' Q1 Net Loss Widens - marketscreener.com
Vera Therapeutics (VERA) Awaits Key Trial Results for Atacicept - GuruFocus
Vera Therapeutics (VERA) Awaits Key Trial Results for Atacicept | VERA Stock News - GuruFocus
Earnings Flash (VERA) Vera Therapeutics Posts Q1 Net Loss $0.81 a Share, vs. FactSet Est of $0.75 Loss - marketscreener.com
Vera Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results - The Manila Times
BRIEF-Vera Therapeutics Q1 EPS USD -0.81 Vs. IBES Estimate USD -0.74 - TradingView
Vera Therapeutics (NASDAQ:VERA) Coverage Initiated by Analysts at HC Wainwright - Defense World
Vera Therapeutics (VERA) Gains Positive Outlook with Buy Rating - GuruFocus
Vera Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks
Vera Therapeutics (VERA) Receives New Buy Rating from HC Wainwri - GuruFocus
(VERA) On The My Stocks Page - news.stocktradersdaily.com
Invesco Ltd. Raises Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
A History of Outperforming Analyst Forecasts and Beating the Odds: Vera Therapeutics Inc (VERA) - Sete News
Vera Therapeutics Inc (VERA) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
Insider’s View: Deciphering Vera Therapeutics Inc (VERA)’s Financial Health Through Ratios - DWinneX
Vera Therapeutics Inc (VERA)’s stock performance: a year in review - uspostnews.com
Vera Therapeutics (VERA) Expected to Announce Earnings on Thursday - Defense World
Vera Therapeutics Inc (VERA) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Renaissance Technologies LLC Makes New Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - The AM Reporter
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Acquired by Wells Fargo & Company MN - Defense World
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):